Anti-Retroviral Therapy
Antiretroviral therapy refers to HIV treatment that uses a combination of two or more antiretroviral drugs. Antiretroviral therapy revolutionized HIV treatment upon its introduction in 1996. Antiretroviral therapy is an effective treatment for HIV. It does not cure the condition, but it can reduce the viral load to undetectable levels. This means that the virus is not transmittable through sexual activity and a person's immune system can recover. It usually takes around 3–6 months for the viral load to reach undetectable levels.fatal disease into a manageable chronic condition, it does not cure HIV. Lifelong adherence to ART is necessary to maintain viral suppression and prevent drug resistance, which can arise if therapy is interrupted or if there are insufficient drug levels. ART has significantly improved the prognosis for people with HIV, reducing the rates of opportunistic infections, preventing HIV-related complications, and increasing life expectancy. However, ART is not without challenges. Some patients experience side effects, such as gastrointestinal problems, fatigue, or metabolic changes, and adherence can be difficult due to the complexity of treatment regimens or socioeconomic barriers. Additionally, the emergence of drug-resistant HIV strains remains a concern, requiring careful management of ART regimens to ensure continued efficacy.
Related Conference of Anti-Retroviral Therapy
10th International Conference on Molecular Medicine and Diagnostics
9th International Conference on Microbiome, Probiotics & Gut Nutrition
8th International Conference on Antimicrobial and Antibacterial Agents
7th International Conference on Applied Microbiology and Infectious Diseases
8th International Conference on Clinical Microbiology, Virology and Infectious Diseases
21st International Conference on Microbial Interactions & Microbial Ecology
12th International Congress on Trauma, Critical Care and Emergency Medicine
Anti-Retroviral Therapy Conference Speakers
Recommended Sessions
- Animal Virology
- Anti-Retroviral Therapy
- Antiviral Drug Discovery and Development
- Bacterial and Fungal Virology
- Clinical and Diagnostic Virology
- Coronavirus (COVID-19)
- Current Focus in Virology Research
- Gastrointestinal viral diseases
- General Virology
- Hepatic viral diseases
- Insect vector and virus epidemiology
- Microbiology
- Molecular and Cellular Virology
- Neurologic viral diseases
- Pediatric Viral Infectious Diseases
- Plant and Agricultural Virology
- Respiratory viral diseases
- STD & HIV/ AIDS and Emerging Viral Diseases
- Viral Immunology
- Viral Oncology
- Viral Vaccines
Related Journals
Are you interested in
- 16S Sequencing and Analysis - Microbiome 2025 (Canada)
- Acute Care Surgery - TRAUMA 2026 (France)
- Agriculture & Forest Microbiology - Microbial Interactions 2026 (France)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2025 (Canada)
- Antimicrobial Agents & Resistance - Microbial Interactions 2026 (France)
- Applied and Environmental Science - Microbial Interactions 2026 (France)
- Aquatic & Marine Microbiology - Microbial Interactions 2026 (France)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2025 (Canada)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2025 (Canada)
- Benefits of Biostimulants - Microbiome 2025 (Canada)
- Bioinformatics for Microbiome - Microbiome 2025 (Canada)
- Biostimulants and Biocontrol Strategies - Microbiome 2025 (Canada)
- Burns and Thermal Injuries - TRAUMA 2026 (France)
- Cardiac and Vascular Emergencies - TRAUMA 2026 (France)
- Cellular Microbiology & Systems Microbiology - Microbial Interactions 2026 (France)
- Clinical and Public Health Microbiology - Microbial Interactions 2026 (France)
- Critical Care Medicine - TRAUMA 2026 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2026 (France)
- Emerging Infectious Diseases in Critical Care - TRAUMA 2026 (France)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2026 (France)
- Food & Marine Microbiology - Microbial Interactions 2026 (France)
- Geriatric Trauma and Emergency Care - TRAUMA 2026 (France)
- Global Health and Trauma Care - TRAUMA 2026 (France)
- Harnessing PhytoMicrobiome Signaling for Microbiome Engineering - Microbiome 2025 (Canada)
- Horticulture Hydroponics and Microbiomes - Microbiome 2025 (Canada)
- Host-Pathogen Interaction - Microbial Interactions 2026 (France)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbial Interactions 2026 (France)
- Innovations and Technology in Trauma and Critical Care - TRAUMA 2026 (France)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events, and Colorectal Cancer - Microbiome 2025 (Canada)
- Microbial Biodegradation - Microbial Interactions 2026 (France)
- Microbial Community - Microbial Interactions 2026 (France)
- Microbial Diseases - Microbial Interactions 2026 (France)
- Microbial Ecology and Evolution - Microbial Interactions 2026 (France)
- Microbial Interactions - Microbial Interactions 2026 (France)
- Microbial Pathogenesis - Microbial Interactions 2026 (France)
- Microbiology & Infectious Diseases - Microbial Interactions 2026 (France)
- Microbiome as a Human Organ - Microbiome 2025 (Canada)
- Microbiome- Science Comes to Life - Microbiome 2025 (Canada)
- Military and Combat Trauma - TRAUMA 2026 (France)
- Modulation of Microbiota - Microbiome 2025 (Canada)
- Molecular Microbiology - Microbial Interactions 2026 (France)
- Mycology, Fungal Pathogens and Associated Diseases - Microbial Interactions 2026 (France)
- Neurological Emergencies and Trauma - TRAUMA 2026 (France)
- Pediatric and Neonatal Emergency Care - TRAUMA 2026 (France)
- Pediatric Microbiome-Vaginal Delivery vs. C-Section - Microbiome 2025 (Canada)
- Pharmacogenomics and the Microbiome - Microbiome 2025 (Canada)
- Plant Beneficial Microbes - Microbiome 2025 (Canada)
- Plant Conditioners (Biostimulants) - Microbiome 2025 (Canada)
- Plant Pathology & Microbiology - Microbial Interactions 2026 (France)
- Plant-Soil Microbe Interactions - Microbial Interactions 2026 (France)
- Prebiotics and Probiotics - Microbiome 2025 (Canada)
- Psychosocial Aspects of Trauma and Critical Care - TRAUMA 2026 (France)
- Resuscitation and Emergency Response - TRAUMA 2026 (France)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2025 (Canada)
- Signaling in the PhytoMicrobiome - Microbiome 2025 (Canada)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2025 (Canada)
- Soil microbiology & Water Microbiology - Microbial Interactions 2026 (France)
- The Globalization of Cannabis Cultivation-A Growing Challenge - Microbiome 2025 (Canada)
- The Gut Microbiota-Centerpiece of Human Health - Microbiome 2025 (Canada)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2025 (Canada)
- The Microbiome in Cancer Development and Therapy - Microbiome 2025 (Canada)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2025 (Canada)
- The Skin Microbiome - Microbiome 2025 (Canada)
- Trauma and Emergency Care Research - TRAUMA 2026 (France)
- Trauma and Emergency Medicine - TRAUMA 2026 (France)
- Trauma and Emergency Medicine Education - TRAUMA 2026 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2026 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2026 (France)
